Dynapenia and Sarcopenia in Post-COVID-19 Syndrome Hospitalized Patients Are Associated with Severe Reduction in Pulmonary Function
Authors:
- Arturo Orea-TejedaAOArturo Orea-Tejeda
- Robinson Robles-HernándezRobinson Robles-Hernández
- Dulce González-IslasDGDulce González-Islas
- Luz Jimenez-GallardoLJLuz Jimenez-Gallardo
- Laura Gochicoa-RangelLGLaura Gochicoa-Rangel
- Armando Castorena-MaldonadoACArmando Castorena-Maldonado
- Rafael Hernández-ZentenoRHRafael Hernández-Zenteno
- Alvaro Montañez-OrozcoAMAlvaro Montañez-Orozco
- Benigno Valderrábano-SalasBVBenigno Valderrábano-Salas
Open Access
- 11 October 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (20) , 6466
Abstract
Background: After hospital discharge, post-COVID-19 syndrome has been observed to be associated with impaired diffusing capacity, respiratory muscle strength, and lung imaging abnormalities, in addition to loss of muscle mass/strength, sarcopenia, and obesity impact exercise tolerance, pulmonary functions, and overall prognosis. However, the relationship between lung function and the coexistence of obesity with low muscle strength and sarcopenia in post-COVID-19 patients remains poorly investigated. Therefore, our aim was to evaluate the association between lung function and the coexistence of obesity with dynapenia and sarcopenia in post-COVID-19 syndrome patients. Methods: This cross-sectional study included subjects who were hospitalized due to moderate to severe COVID-19, as confirmed by PCR testing. Subjects who could not be contacted, declined to participate, or died before the follow-up visit were excluded. Results: A total of 711 subjects were evaluated; the mean age was 53.64 ± 13.57 years, 12.4% had normal weight, 12.6% were dynapenic without obesity, 8.3% had sarcopenia, 41.6% had obesity, 21.2% had dynapenic obesity, and 3.8% had sarcopenic obesity. In terms of pulmonary function, the dynapenic subjects showed decreases of −3.45% in FEV1, −12.61 cmH2O in MIP, and -12.85 cmH2O in MEP. On the other hand, the sarcopenic subjects showed decreases of −6.14 cmH2O in MIP and −11.64 cmH2O in MEP. The dynapenic obesity group displayed a reduction of −12.13% in PEF. Conclusions: In post-COVID-19 syndrome, dynapenia and sarcopenia—both with and without obesity—have been associated with lower lung function.Keywords
This publication has 68 references indexed in Scilit:
- Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort studyEuropean Respiratory Journal, 2013
- Exercise Limitations by the Oxygen Delivery and Utilization Systems in Aging and Disease: Coordinated Adaptation and Deadaptation of the Lung-Heart Muscle Axis - A Mini-ReviewGerontology, 2012
- Waist circumference and pulmonary function: a systematic review and meta-analysisSystematic Reviews, 2012
- Association of Weight Status With Mortality in Adults With Incident DiabetesJAMA, 2012
- Decline in skeletal muscle mitochondrial function with aging in humansProceedings of the National Academy of Sciences, 2005
- Respiratory muscle fibres: specialisation and plasticityThorax, 2004
- ATS/ERS Statement on Respiratory Muscle TestingAmerican Journal of Respiratory and Critical Care Medicine, 2002
- The impact of obesity on the short-term andlong-term outcomes after percutaneous coronary intervention: the obesity paradox?JACC, 2002
- Pulmonary Function Is a Long-term Predictor of Mortality in the General PopulationChest, 2000
- Spirometric Reference Values from a Sample of the General U.S. PopulationAmerican Journal of Respiratory and Critical Care Medicine, 1999